Ralph Hauke
Medical Journal Articles
| Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide |
Read Article |
| Sequential Therapy in Metastatic Renal Cell Carcinoma |
Read Article |
| Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement |
Read Article |
| Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study |
Read Article |
| Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer |
Read Article |
| Abstract CT134: Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment: |
Read Article |
| A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma |
Read Article |
| Prostate Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement |
Read Article |
| Immunological Basis in the Pathogenesis and Treatment of Bladder Cancer |
Read Article |
| Immunological Effects and Therapeutic Role of C5a in Cancer |
Read Article |
To Read Additional Articles please visit: https://www.researchgate.net/profile/Ralph-Hauke
